IVERIC Bio Valuation
| ISEEDelisted Stock | USD 39.95 0.00 0.00% |
At this time, the firm appears to be overvalued. IVERIC Bio retains a regular Real Value of $31.48 per share. The prevalent price of the firm is $39.95. Our model calculates the value of IVERIC Bio from analyzing the firm fundamentals such as Return On Asset of -0.3, return on equity of -0.55, and Shares Outstanding of 137.98 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that IVERIC Bio's price fluctuation is very steady at this time. Calculation of the real value of IVERIC Bio is based on 3 months time horizon. Increasing IVERIC Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the IVERIC stock is determined by what a typical buyer is willing to pay for full or partial control of IVERIC Bio. Since IVERIC Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IVERIC Stock. However, IVERIC Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.95 | Real 31.48 | Hype 39.95 | Naive 39.16 |
The real value of IVERIC Stock, also known as its intrinsic value, is the underlying worth of IVERIC Bio Company, which is reflected in its stock price. It is based on IVERIC Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of IVERIC Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of IVERIC Bio helps investors to forecast how IVERIC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IVERIC Bio more accurately as focusing exclusively on IVERIC Bio's fundamentals will not take into account other important factors: IVERIC Bio Total Value Analysis
IVERIC Bio is currently forecasted to have valuation of 4.98 B with market capitalization of 5.51 B, debt of 97.77 M, and cash on hands of 311.96 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the IVERIC Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.98 B | 5.51 B | 97.77 M | 311.96 M |
IVERIC Bio Asset Utilization
One of the ways to look at asset utilization of IVERIC is to check how much profit was generated for every dollar of assets it reports. IVERIC Bio retains a negative application of resources of -0.3 (percent), losing $0.002964 for each dollar of resources held by the firm. Inefficient asset utilization attests that the company is being less competent with each dollar of resources it retains. Simply put, asset utilization of IVERIC Bio shows how inadequate it operates for each dollar spent on its resources.IVERIC Bio Ownership Allocation
The majority of IVERIC Bio outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IVERIC Bio to benefit from reduced commissions. Therefore, third-party entities are subject to a different set of regulations than regular investors in IVERIC Bio. Please pay attention to any change in the institutional holdings of IVERIC Bio as this could imply that something significant has changed or is about to change at the company.IVERIC Bio Profitability Analysis
Net Loss for the year was (185.21 M) with loss before overhead, payroll, taxes, and interest of (117.01 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates IVERIC Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in IVERIC Bio and how it compares across the competition.
About IVERIC Bio Valuation
The delisted stock valuation mechanism determines IVERIC Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of IVERIC Bio. We calculate exposure to IVERIC Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IVERIC Bio's related companies.IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases . The company was incorporated in 2007 and is based in Parsippany, New Jersey. Iveric Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.
IVERIC Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as IVERIC Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 121 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in IVERIC Stock
If you are still planning to invest in IVERIC Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IVERIC Bio's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |